Evidence map›Paper›PMID 35930644›Full record

ArticleScience advances2022

Thermal stabilization of diverse biologics using reversible hydrogels.

Bruno Marco-Dufort, John R Janczy, Tianjing Hu, Marco Lütolf, Francesco Gatti, Morris Wolf, Alex Woods, Stephan Tetter, Balaji V Sridhar, Mark W Tibbitt

Abstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. On-Demand Chemically Degradable Hydrogels for Biological Applications.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Tailoring biomaterials for vaccine delivery.Journal of nanobiotechnology · 2024
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bruno Marco-DufortMacromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.ORCID 0000-0001-9098-9964
John R JanczyNanoly Bioscience Inc., Denver, CO 80231, USA.
Tianjing HuNanoly Bioscience Inc., Denver, CO 80231, USA.
Marco LütolfMacromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.
Francesco GattiMacromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.
Morris WolfMacromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.ORCID 0000-0002-1328-1345
Alex WoodsNanoly Bioscience Inc., Denver, CO 80231, USA.
Stephan TetterLaboratory of Organic Chemistry, ETH Zurich, 8093 Zurich, Switzerland.ORCID 0000-0002-4175-0225
Balaji V SridharNanoly Bioscience Inc., Denver, CO 80231, USA.
Mark W TibbittMacromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.ORCID 0000-0002-4917-7187

Funding

Development of NanoShield for Ambient handling of labile Bio-productsR43GM128466 · NIGMS · TOPOGEN, INC. · PI MULLER, MARK, SRIDHAR, BALAJI V · 2018 to 2019
$512k
NIGMS NIH HHS R43 GM128466
6 · The paper itself

Abstract

Improving the thermal stability of biologics, including vaccines, is critical to reduce the economic costs and health risks associated with the cold chain. Here, we designed a versatile, safe, and easy-to-use reversible PEG-based hydrogel platform formed via dynamic covalent boronic ester cross-linking for the encapsulation, stabilization, and on-demand release of biologics. Using these reversible hydrogels, we thermally stabilized a wide range of biologics up to 65°C, including model enzymes, heat-sensitive clinical diagnostic enzymes (DNA gyrase and topoisomerase I), protein-based vaccines (H5N1 hemagglutinin), and whole viruses (adenovirus type 5). Our data support a generalized protection mechanism for the thermal stabilization of diverse biologics using direct encapsulation in reversible hydrogels. Furthermore, preliminary toxicology data suggest that the components of our hydrogel are safe for in vivo use. Our reversible hydrogel platform offers a simple material solution to mitigate the costs and risks associated with reliance on a continuous cold chain for biologic transport and storage.

Identifiers

PMID35930644
PMCPMC9355364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.